QuidelOrtho Corporation f/k/a Quidel Corporation Sued for Securities Law Violations - Contact Levi & Korsinsky Before June 11, 2024 to Discuss Your Rights - QDEL
NEW YORK, NY / ACCESSWIRE / May 30, 2024 / If you suffered a loss on your QuidelOrtho Corporation f/k/a Quidel Corporation (NASDAQ:QDEL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
QDEL LAWSUIT ALERT: Levi & Korsinsky Notifies QuidelOrtho Corporation f/k/a Quidel Corporation Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, NY / ACCESSWIRE / May 30, 2024 / If you suffered a loss on your QuidelOrtho Corporation f/k/a Quidel Corporation (NASDAQ:QDEL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
Contact Hagens Berman by June 11, 2024 Deadline to Join Class Action Against QuidelOrtho (QDEL)
SAN FRANCISCO, CA / ACCESSWIRE / May 30, 2024 / Hagens Berman urges QuidelOrtho Corporation (NASDAQ:QDEL) investors who suffered substantial losses to submit your losses now. Class Period: Feb. 18, 2022 - Apr. 1, 2024 Lead Plaintiff Deadline: June 11, 2024 Visit: www.hbsslaw.com/investor-fraud/QDEL Contact the Firm Now: [email protected] 844-916-0895 QuidelOrtho Corporation (NASDAQ: QDEL) Securities Class Action: The litigation is focused on the propriety of QuidelOrtho's past assurances about its preparedness to maintain a stable high margin revenue stream from its respiratory business in the face of the COVID-19 pandemic becoming an endemic and about its FDA submission for its purported "next flagship product" (the "Savanna RVP4 Test") being "on track.
Shareholders of QuidelOrtho Corporation f/k/a Quidel Corporation Should Contact Levi & Korsinsky Before June 11, 2024 to Discuss Your Rights – QDEL
NEW YORK, NY / ACCESSWIRE / May 30, 2024 / If you suffered a loss on your QuidelOrtho Corporation f/k/a Quidel Corporation (NASDAQ:QDEL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
Shareholders of QuidelOrtho Corporation f/k/a Quidel Corporation Should Contact Levi & Korsinsky Before June 11, 2024 to Discuss Your Rights - QDEL
NEW YORK, NY / ACCESSWIRE / May 20, 2024 / If you suffered a loss on your QuidelOrtho Corporation f/k/a Quidel Corporation (NASDAQ:QDEL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
Levi & Korsinsky Reminds QuidelOrtho Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 11, 2024 - QDEL
NEW YORK, NY / ACCESSWIRE / May 20, 2024 / If you suffered a loss on your QuidelOrtho Corporation f/k/a Quidel Corporation (NASDAQ:QDEL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
International Assets Investment Management LLC Purchases 7,781 Shares of QuidelOrtho Co. (NASDAQ:QDEL)
International Assets Investment Management LLC raised its position in shares of QuidelOrtho Co. (NASDAQ:QDEL – Free Report) by 7,410.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7,886 shares of the company’s stock after purchasing an additional 7,781 shares during the period. International Assets Investment Management LLC’s holdings in QuidelOrtho were worth $581,000 at the end of the most recent reporting period. Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. C M Bidwell & Associates Ltd. acquired a new position in shares of QuidelOrtho during the 3rd quarter worth $123,000. William Blair Investment Management LLC bought a new position in QuidelOrtho in the third quarter valued at about $210,000. New York Life Investment Management LLC acquired a new position in QuidelOrtho during the third quarter worth about $376,000. QRG Capital Management Inc. bought a new position in shares of QuidelOrtho in the third quarter worth about $410,000. Finally, Citigroup Inc. boosted its stake in shares of QuidelOrtho by 25.0% in the 3rd quarter. Citigroup Inc. now owns 5,808 shares of the company’s stock valued at $424,000 after purchasing an additional 1,161 shares in the last quarter. 99.00% of the stock is currently owned by institutional investors. QuidelOrtho Stock Down 2.7 % Shares of QDEL opened at $42.82 on Monday. The stock’s 50-day moving average price is $43.69 and its two-hundred day moving average price is $57.17. QuidelOrtho Co. has a 12 month low of $37.78 and a 12 month high of $90.45. The company has a market capitalization of $2.87 billion, a PE ratio of -1.62 and a beta of 0.17. The company has a current ratio of 1.55, a quick ratio of 0.81 and a debt-to-equity ratio of 0.68. Insider Buying and Selling In other news, CFO Joseph M. Busky bought 2,150 shares of the firm’s stock in a transaction on Friday, February 23rd. The stock was acquired at an average price of $46.35 per share, with a total value of $99,652.50. Following the transaction, the chief financial officer now owns 2,150 shares of the company’s stock, valued at approximately $99,652.50. The acquisition was disclosed in a document filed with the SEC, which is available through this link. 1.00% of the stock is owned by insiders. Analyst Upgrades and Downgrades Several equities research analysts recently issued reports on the stock. Royal Bank of Canada decreased their price target on shares of QuidelOrtho from $81.00 to $68.00 and set an “outperform” rating on the stock in a report on Thursday, May 9th. William Blair reiterated a “market perform” rating on shares of QuidelOrtho in a report on Wednesday, February 14th. UBS Group reiterated a “sell” rating and issued a $42.00 price target (down from $70.00) on shares of QuidelOrtho in a research note on Monday, March 4th. Craig Hallum restated a “hold” rating on shares of QuidelOrtho in a research report on Wednesday, February 14th. Finally, JPMorgan Chase & Co. downgraded QuidelOrtho from a “neutral” rating to an “underweight” rating and dropped their target price for the company from $66.00 to $37.00 in a research report on Wednesday, February 14th. Two equities research analysts have rated the stock with a sell rating, four have assigned a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat, QuidelOrtho presently has an average rating of “Hold” and an average price target of $59.00. Get Our Latest Research Report on QuidelOrtho About QuidelOrtho (Free Report) QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions.
Levi & Korsinsky Reminds QuidelOrtho Corporation f/k/a Quidel Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 11, 2024 - QDEL
NEW YORK, NY / ACCESSWIRE / May 19, 2024 / If you suffered a loss on your QuidelOrtho Corporation f/k/a Quidel Corporation (NASDAQ:QDEL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
QuidelOrtho Corporation f/k/a Quidel Corporation Class Action: Levi & Korsinsky Reminds QuidelOrtho Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 11, 2024 - QDEL
NEW YORK, NY / ACCESSWIRE / May 19, 2024 / If you suffered a loss on your QuidelOrtho Corporation f/k/a Quidel Corporation (NASDAQ:QDEL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
IMPORTANT INVESTOR ALERT: The Schall Law Firm Encourages Investors in QuidelOrtho Corporation with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / May 19, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against QuidelOrtho Corporation ("QuidelOrtho" or "the Company") (NASDAQ:QDEL) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 18, 2022 and April 1, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before June 11, 2024.
Levi & Korsinsky Notifies QuidelOrtho Corporation f/k/a Quidel Corporation Investors of a Class Action Lawsuit and Upcoming Deadline - QDEL
NEW YORK, NY / ACCESSWIRE / May 19, 2024 / If you suffered a loss on your QuidelOrtho Corporation f/k/a Quidel Corporation (NASDAQ:QDEL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
QDEL LAWSUIT ALERT: Levi & Korsinsky Notifies QuidelOrtho Corporation f/k/a Quidel Corporation Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, NY / ACCESSWIRE / May 19, 2024 / If you suffered a loss on your QuidelOrtho Corporation f/k/a Quidel Corporation (NASDAQ:QDEL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
